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ABSTRACT
Opioid addiction and misuse have become widespread in the U.S. over the past
decade, causing a rise in opioid related mortality. High opioid prescribing rates have led
public health agencies to examine provider prescribing practices. Research has identified
provider characteristics such as gender, age, and years of experience are predictive of
opioid prescribing in human medical providers. Veterinarians are frequently licensed to
prescribe opioids, yet less is known about the prescribing practices of veterinarians. From
a public health perspective, it is important to explore the potential connection between
veterinary medicine and the opioid epidemic. The current study assessed whether
variations in provider characteristics have similar patterns of influence on veterinary
prescribing behaviors. Survey participants (n=369, response rate 48%) were veterinarians
currently practicing and licensed through the Idaho Board of Veterinary Medicine. A
hierarchical multiple regression model was employed using the sum score of opioid
prescribing frequency as the dependent variable (F(4, 352) = 8.52, p < 0.05, R2 =.09).
Four independent variables (gender, age, years of experience, and opioid education
received in veterinary school) predicted provider characteristics. Of the characteristics
selected for analysis, younger age and female gender significantly predicted higher opioid
prescribing rates. When opioid education was included in the model, only gender
remained significant. This study suggests that while physician characteristics can predict
opioid prescribing behaviors in human healthcare providers, these characteristics do not
seem to have the same influence on opioid prescribing in Idaho’s veterinary population.
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CHAPTER I: INTRODUCTION
The United States is in the midst of an opioid epidemic that according to the
Centers for Disease Control and Prevention (2019) has already resulted in the deaths of
over 700,000 people. In fact, medication overdose (caused by legal or illegal drugs, as
well as medically prescribed and other drugs) has become the number one cause of
accidental death in the United States (Kochanek, Murphy, Xu & Arias, 2019). Nationally,
the drug-induced death rate has increased by nearly 40 percent over the past decade,
while in the state of Idaho this rate has increased by more than 75 percent (Shaw-Tulloch,
2017). Government and public health agencies have mobilized in response to the crisis
through law enforcement, legislation, education and other initiatives, yet these efforts to
impact the opioid epidemic have primarily focused on human medical providers,
pharmacists and patients. The role of veterinary medicine in the opioid epidemic remains
largely unknown, even though many veterinarians hold DEA licenses and can prescribe,
administer, carry, and dispense opioids. The general absence of targeted veterinary data
has led to questions about the potential role the veterinary profession may play in the
opioid crisis. In 2017, the American Veterinary Medical Association formed the Working
Group on Opioid Issues and has called for more research to help determine the impact of
veterinary prescribing practices on the human opioid epidemic (American Veterinary
Medical Association [AVMA], 2020). State veterinary organizations have echoed this
appeal, with the Idaho Veterinary Medical Association (IVMA) and the Idaho Board of
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Veterinary Medicine (IBVM) requesting a more detailed understanding of the
relationship between veterinarians and the current opioid epidemic.
Purpose of the Study
The CDC has identified the overprescribing of prescription opioids as one of the
primary drivers behind the increase in the number of opioid overdoses; federal agencies
monitoring and investigating the course of the opioid epidemic have identified the abuse
of prescription opioids as the principal cause of drug overdose deaths (Wood, 2015). In
response, government agencies and public health initiatives began aggressively targeting
opioid prescribing practices with new dispensing guidelines, changes to manufacturing
availability, and widespread implementation of prescription drug monitoring programs.
Some states now require a background check before an opioid prescription can be written
(Clarke, Drobatz, Korzekwa, Nelson & Perrone, 2019; McReynolds, 2019). Other
guidelines limit the amount or duration of opioid prescriptions (Kogan, Hellyer, Rishniw
& Schoenfeld-Tacher, 2019; McReynolds, 2019). Reduced manufacturing quotas for
oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine, codeine,
meperidine, and fentanyl limit the availability of these analgesics for dispensing or
prescribing (Balik, 2017). Despite these initiatives, the number of opioid prescriptions
has increased disproportionately compared to the number of patient visits (Clarke et al.,
2019; McReynolds, 2019). While the monitoring of opioid prescriptions has increased for
medical providers, there is relatively little research concerning opioid prescribing
practices in veterinary medicine. Surveys of veterinarians in other states have identified
opioid prescribing practices to be a significant research gap (Mason, Tenney, Hellyer &
Newman, 2018). In order to help address this gap, a survey questionnaire was created to
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assess how Idaho veterinarians currently utilize and prescribe opioids in their clinical
practice, evaluate opioid resources and education, and better understand their current
awareness of the opioid crisis. This research will allow the IVMA, the IBVM, the Idaho
Department of Health and Welfare and other stakeholders to make informed decisions,
allocate resources, create targeted interventions, and better serve the public health needs
of Idahoans.
Study Questions
This research study was undertaken to examine whether variations in provider
characteristics can have any influence on veterinary opioid prescribing behavior.
Specifically, this study aimed to determine whether variations in provider characteristics
could predict the same patterns of opioid prescribing behavior in veterinarians as they do
for human physicians. Gender, age, and years of experience were three variables chosen
for this study as these are the provider characteristics frequently reviewed in analogous
research studies surveying human medical providers. Research into the characteristics of
human physicians examined an additional variable of interest to this study: provider
education related to opioid training. To investigate the influence of provider education,
opioid training received during veterinary school was also evaluated as an outcome
variable in a separate prediction model.
Importance of the Study
Research has identified provider characteristics as a predictor of opioid
prescribing patterns for human physicians; understanding and accounting for these factors
is paramount to effective strategy development and may have a considerable impact on
the success or failure of policies and programs designed to combat the opioid crisis.
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Existing studies have identified the relationship between physician characteristics and
opioid prescribing patterns in human medical practice; to our knowledge, similar research
into the influence of veterinary provider characteristics on opioid prescribing behaviors
has not yet been undertaken. A more comprehensive awareness of whether veterinary
provider characteristics are predictive of opioid prescribing behaviors may help answer
whether veterinarians, like physicians, have a role in the current opioid epidemic. The
results of this study could provide a foundation for future research as well as inform
strategies and interventions seeking to target opioid prescribing behaviors.
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CHAPTER II: LITERATURE REVIEW
In recent decades, from the late 1990’s through the present, the United States has
experienced an unprecedented increase in the number of overdose-related deaths
involving prescription and illicit opioid drugs (Centers for Disease Control and
Prevention [CDC], 2018). In 2017, the scale of the opioid epidemic led the Department of
Health and Human Services to declare the crisis a public health emergency (CDC, 2018).
Investigations into the opioid crisis have traced the origins of this epidemic back to an
increase in the rate of opioid prescriptions following growing advocacy for better pain
management and a misunderstanding of opioid addiction potential (deShazo, Johnson,
Eriator & Rodenmeyer, 2018). Between the late 1990s and early 2000s, patient advocacy
groups such as the American Pain Foundation, the American Pain Society, and the
International Association for the Study of Pain began gathering support for better access
to pain management, including opioid therapy for chronic non-cancer pain (deShazo et
al., 2018). Pharmaceutical companies and opioid manufacturers joined in support of
opioid therapy for chronic pain, often providing physicians and patients with coupons for
free supply. Pain studies, advocacy groups, and treatment guidelines supported by
funding from the pharmaceutical industry minimized the abuse potential associated with
opioid use; for example, drug-seeking by pain patients was considered a reflection of pain
under-treatment (deShazo et al., 2018). Sales of prescription opioids quadrupled, despite
reports of pain prevalence remaining the same (Kim, Nolan & Ti, 2017). The number of
overdose related deaths began to rise, with over half (57%) the result of prescription
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opioids (Coston, n.d.). Government and public health agencies mobilized, issuing
recommendations limiting the quantity and duration of opioid prescriptions (Daly,
Ulrich-Schad, Gu, Yingling & Ayres, 2019). The new guidelines resulted in a drop in
opioid prescribing (by an average of eight pills per patient) and in some states reduced
the opioid-related overdose deaths by half (Appleby & Lucas, 2019; Franklin et al.,
2012). Recognizing that there was a relationship between increased opioid prescribing
behavior and opioid dependence, interventions targeting prescribing behaviors were
identified by the National Institute on Drug Abuse as having a “key role in stopping the
opioid overdose epidemic” (2017).
Opioid Physiology
The opioid system is the biological mechanism whereby endogenous or synthetic
opioid proteins interact with receptors throughout the body (Le Merrer, Becker, Befort &
Kieffer, 2009). Opioid receptors are structural membrane proteins which become
activated when bound to opioid proteins with a corresponding selectivity and affinity,
similar to complementary puzzle pieces (Koneru, Satyanarayana & Rizwan, 2009). Four
types of opioid binding sites have so far been identified: the mu, delta, kappa, and
orphanin FQ opioid receptors (Stevens, 2009). Studies have confirmed the first three of
these receptors result in a physiological analgesic effect when activated (Stevens, 2009).
Acting on these receptors are the four categories of opioids: agonists (which have
a high affinity for mu receptors), partial agonists, antagonists (with affinity for both mu
and kappa receptors) and mixed agonists/antagonists (McNerney, 2017). Agonists are
drugs that, by binding to matching receptors, result in a biologic response; an antagonist,
by contrast, is a drug that blocks the biological response from occurring (Kahn & Line,
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2005). Activated opioid receptors control physiological responses such as blood pressure
and body temperature, cardiac regulation, and respiration (Vuong, Van Uum, O’Dell,
Lufty & Friedman, 2009). The location of opioid receptors throughout the body’s central
and peripheral nervous system, brain, and gastrointestinal tract is the reason opioid
overdose requires such little effort—by occupying these receptors, the body is unable to
perform its normal functions, including heartrate and breathing (U.S. National Library of
Medicine, 2018).
Opioid Utilization in Veterinary Medicine
Human and animal medicine have had a common trajectory, sharing scientific
achievement and discovery over the centuries—from the microscope and germ theory to
anesthesia and pharmacologic advancement. Spinal anesthesia, such as that used during
childbirth, can be attributed to the discovery that synthetic morphine administered into
the spinal cord of a dog produced a temporary anesthetic effect (Goyal, 2015). The
introduction of human ophthalmic surgery was made possible after it was discovered that
a solution of cocaine applied to the eyes of a dog would produce a localized anesthetic
effect (Goyal, 2015). Animals, like humans, have receptors capable of being activated by
opioid agonists and antagonists. The mu opioid receptors in particular could be
characterized as being one of the most well-conserved among animal species, including
humans (Myers & Jung, 2009). While there is greater scientific familiarity with the
opioid receptors in domestic animals such as dogs, cats and horses, or in laboratory
research animals such as rats and mice, science has also discovered opioid receptors in
reptiles, birds, fish, and even invertebrates such as the mollusk (KuKanish and Wiese,
2017).
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Opioids are used in the treatment of animals for a variety of purposes depending
on species and clinical need, but they function primarily for pain management (Dohoo &
Dohoo, 1996). Even with differences in sensitivity and biological response between
species, opioids remain one of the most effective treatments for acute pain (Kahn & Line,
2005). The plasticity of opioid analgesics is particularly important in veterinary medicine
as there is a wide variety in patient size, species, temperament and metabolic demand.
For example, opioid drugs can be combined—which allows for the dose-reduction of
individual drugs—or even reversed, which increases patient safety (Kahn & Line, 2005).
In addition, opioid administration routes can vary widely, allowing for flexibility in a
diverse patient population; opioid administration may be oral, transmucosal, transdermal,
intramuscular, intravenous, intraspinal, or inhaled depending on the drug and the species
(Burwaiss, 2013).
Commonly used opioids in veterinary medicine include hydromorphone,
morphine, fentanyl, codeine, hydrocodone, buprenorphine, butorphanol, and tramadol.
Opioid drugs utilized within the scope of veterinary medical practice are regulated by
either the Food and Drug Administration (responsible for drug safety) or the U.S. Drug
Enforcement Agency (DEA). The DEA defines controlled substances under the federal
Controlled Substances Act (CSA), but does not regulate the practice of veterinary
medicine; regulations pertaining to the prescription of opioids and other controlled
substances is under state control. In the state of Idaho, veterinary controlled substance
regulations are outlined in Section 154 of the Idaho Administrative Code entitled, “Rules
of the State Board of Veterinary Medicine,” which identifies requirements for appropriate
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purchase, administration, dispensing, record-keeping, and disposal of controlled
substances (Rules of the State Board of Veterinary Medicine of 1997).
Provider Characteristics and Opioid Prescribing Behavior
Public health agencies that include the CDC, the DEA, and the National Institutes
of Health (NIH) have established a clear relationship between opioid over-prescribing
and a patient’s risk of opioid dependence (Meisenberg, Grover, Campbell & Korpon,
2018). While training and clinical indications predominantly guide the decision to
prescribe an opioid, studies have found opioid prescribing behavior can also be predicted
by gender, age, years of experience, and other provider characteristics (Lebovits, et al.,
1997).
Gender
It has been well established within the medical literature that gender disparities
exist in the process of clinical decision making. For example, male and female physicians
have been found to differ in their decision to initiate preventative screening or whether or
not to diagnose a medical condition (Hendersen & Weisman, 2001; McKinlay, Lin,
Freund, & Moskowitz, 2002). They differ when deciding to order testing or whether to
refer a patient to a specialist (Paull, 2015; Borum, 2000). Even surgical technique can
vary between female and male surgeons performing the same procedure (Naidu &
Patrick, 2011). Additionally, gender has been found to be predictive of opioid prescribing
patterns. Varney et al. (2016) identified that female emergency department providers
prescribed fewer opioids than males regardless of concern for prescription opioid abuse.
Other studies have reinforced the influence that male gender has on increased opioid
prescribing behaviors, with male gender frequently predicting for higher opioid rates
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(Huang, Chang, Grogan, Martin & Raldow, 2019). A national survey of opioid
prescribing practices found male surgeons more commonly reported not wanting their
patients to be in pain (Linnaus et al., 2019).
Age
Investigation into the influence of physician age on healthcare outcomes is
common in the medical literature. Studies have found that physician age can impact
willingness to adjust practices in response to clinical evidence or new standards of
treatment (Howard & Hockenberry, 2019). Age can also impact a physician’s
performance with respect to diagnosis, screening and preventative care measures
(Tsugawa, Newhouse, Zaslavsky, Blumenthal & Jena, 2017). Relationships between
patient mortality and physician age have also been observed (Tsugawa et al., 2017).
Physician age was similarly found to predict opioid prescribing behavior, with younger
physicians often prescribing fewer opioids than older physicians. A survey of emergency
room providers found that influences on opioid prescribing behavior most strongly
correlated with physicians younger than 35 years old (Varney et al., 2016). Other studies
have found that younger providers were less confident in their ability to manage pain and
so were more reluctant to prescribe opioids (Jamison, Sheehan, Scanlan, Matthews &
Ross, 2014). Some providers have revealed outdated prescribing practices influenced by
practice habits developed before the opioid crisis (Appleby & Lucas, 2019).
Experience
Clinical experience, or the number of years in practice, has also been found to be
a significant predictor of provider variability in clinical decision-making. Provider
experience can influence a physicians’ estimate of patient survival during illness, or
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whether to adhere to clinical treatment guidelines (Bach, Calhoun & Bennett, 1999;
Cullas, Gunay, Topcu, & Ciftci, 2018). Experience has also been found to be predictive
of opioid prescribing behavior. In general, attending doctors with more training and
experience often prescribe more opioid medications than doctors with less experience
(Varney et al., 2016). Providers with more years since graduation also predicted higher
opioid prescription rates (Huang, Chang, Grogan, Martin & Raldow, 2019). Studies of
emergency room physicians often identify a trend in increased opioid prescribing
behavior by more experienced attending physicians, and that years in practice
significantly predicts opioid prescriptions upon discharge (Leventhal, Nathanson &
Landry, 2019; Varney et al., 2016). A national survey of surgeons found that attending
physicians were less likely to consider opioid diversion when prescribing opioids, and
residents with more experience were more likely to prescribe an increased quantity of
opioids as a result of the inconvenience of calling a refill (Linnaus et al., 2019).
Tracking Veterinary Opioid Prescribing Behavior
Due to the lack of an effective data collection instrument, there is not a lot of
information available about veterinary prescribing behavior. More is known about
physician prescribing behaviors as a result of the widespread implementation of
Prescription Drug Monitoring Programs (PDMPs). A PDMP is a comprehensive,
electronic database used to collect information about a state’s controlled-substance and
opioid prescriptions (Norwood & Wright, 2016). In the scope of human medical care,
PDMPs have become a valuable tool employed by government and public health
agencies to combat the opioid epidemic by tracking provider prescribing information
(Norwood & Wright, 2016). For example, after requiring PDMP utilization, some states
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saw the number of patients who visited multiple physicians for the same drugs decline by
as much as 75 percent (Cima, 2017). All 50 states have enacted legislation requiring these
programs for the reporting of scheduled drugs for human use; currently only 20 states
mandate reporting for veterinarians (Clarke et al., 2019). In the state of Idaho, reporting is
voluntary—Idaho code 37-2726 exempts veterinarians from required registration with the
Prescription Monitoring Program (Food, Drugs & Oil Act of 2005). Designed for human
patients, utilization of state PDMPs for the purpose of understanding veterinary
prescribing behavior is limited. PDMP databases have been unable to effectively navigate
the incompatibility between human and animal medical records and can be further
hindered by the lack of standardized recordkeeping software in veterinary medicine. Most
state PDMPs are not able to differentiate between human and animal prescriptions, and
without permanent, unique identifiers for veterinary patients, veterinarian PDMP access
also raises issues of privacy rights when animal prescriptions are entered into the
database linked to their owners’ prescriptions (Cima, 2017).
With the inability to utilize PDMP databases effectively, veterinary medicine
lacks an equivalent, effective means of collecting data related to prescribing behavior.
This creates a gap in knowledge concerning opioid prescribing behavior that to be
assessed, must utilize a different type of data collection instrument.
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CHAPTER III: METHODS
Participants
Survey participants were recruited through the Idaho Board of Veterinary
Medicine (IBVM) license registration database. Questionnaires were sent via email to
1,068 veterinarians; only currently practicing veterinarians licensed to practice in the
State of Idaho were eligible to participate.
Participants ranged in age from 24 to 79 years, with the average age of
respondents being 48 years old. Just over half of the participants identified themselves as
female (55.4%), with 44.3% identifying as male, and 1% declining to respond. Years of
experience practicing veterinary medicine was fairly evenly distributed among
participants, ranging from fewer than five years (15.0%) to more than 30 years (23.3%),
with the highest percentage of participants having 11-20 years of experience (25.0%).
Respondents included representatives from every type of veterinary specialty, with the
majority of participants (45.4%) selecting ‘Small animal practice’ as their veterinary
specialty, followed next by ‘Mixed animal practice’ at 21.4%. Of these respondents, the
majority (85.4%) hold a DEA license in the State of Idaho.
Survey Design
The initial survey themes were guided by a combination of global and national
veterinary research studies. Search terms were developed for identifying literature
relevant to opioid use in veterinary medicine. The results of the search revealed several
recurring themes: 1. awareness and knowledge of opioid abuse by clients or staff, 2.
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utilization and prescribing practices of opioids and other controlled substances, 3.
attitudes and beliefs concerning opioids and controlled substances, 4. opioid and
controlled substance education and training, and 5. the impact of the opioid epidemic on
veterinary medicine, including the veterinarian’s role in the epidemic. A review of similar
surveys and questionnaires deployed by other state veterinary boards, national veterinary
publications, and related industries (e.g. veterinary compounding pharmacies) narrowed
the survey content and provided more focused questions with targeted language. The
survey was created and distributed to a sample of local and state veterinarians from the
Idaho Board of Veterinary Medicine (IBVM), the Idaho Veterinary Medical Association
(IVMA), and the Idaho Department of Health and Welfare (IDHW) who assessed the
survey for content, question ambiguity, and appropriate response selections. Their
feedback was incorporated into the final version of the electronic survey.
This study’s pilot survey was designed to develop a more detailed understanding
of how veterinarians in Idaho are currently using and prescribing opioids and controlled
substances. Consisting of 48 questions estimated to be completed within 15 minutes, the
questionnaire consisted of five sections:
Section I: Demographics
Questions asked for demographic information such as gender, age, ethnicity,
veterinary specialty (small animal practice, large animal practice, etc.), and number of
years spent practicing veterinary medicine.
Section II: In-house Opioid Use
This section of the survey contained questions focused on the utilization of
controlled substances (including opioids), centering on controlled substance use only
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within the veterinary setting (i.e. pertaining to medications solely utilized in the practice,
not sent home with clients/patients). Respondents were asked to identify the estimated
frequency of controlled substance utilization from a list of the most commonly available
Schedule II through Schedule IV medications. Respondents were asked to identify any
difficulties or shortages of these drugs following interventions related to the opioid crisis,
as well as to provide insight into the storage, access, and disposal of controlled
substances within the practice.
Section III: Dispensing and Prescribing
This section asked respondents to answer questions regarding their controlled
substance dispensing and prescribing practices (i.e. pertaining to medications to be
administered to patients at home and excluding utilization within the practice setting).
Questions aimed to gather information concerning where prescriptions were filled by
clients, whether at human pharmacy, online pharmacy, or in-house pharmacy.
Respondents were asked about which clinical circumstances warranted prescribing or
dispensing of controlled substances (soft tissue surgery, cancer pain, etc.), and to estimate
the frequency of controlled substances prescribed/dispensed.
Section IV: Awareness of Abuse Potential
Skip logic allowed respondents who neither used nor prescribed opioids to
complete the remaining two sections (Section IV and V). Section IV of the survey
explored awareness of abuse and/or diversion of controlled substances. Questions asked
whether staff were knowledgeable about the potential for diversion, whether or not they
were aware of any misuse within their practice or have observed any of the common
warning signs of potential opioid abuse. Respondents were asked whether their opioid
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prescribing practices had changed based on the recent publicity about opioid misuse, and
whether they felt veterinarians played a role in the opioid crisis.
Section V: Education and Training
The final section of the survey explored veterinarians’ opioid education and
training, such as whether survey respondents had received training in veterinary school
for the safe use, storage, and disposal of opioids, the potential for controlled substance
abuse, and best practices for controlled substances. Veterinarians were asked if training
was in place for staff to recognize the signs of opioid abuse, and whether respondents
knew where to report suspicions of controlled substance abuse. Survey respondents were
asked if they were interested in additional opioid education opportunities. (See Appendix
A for a copy of the survey tool).
Both anonymous and confidential, all survey components were approved by the
Boise State Institutional Review board. Survey questions were programmed into
Qualtrics survey software, then electronically mailed to eligible veterinarians. The survey
was sent out in September of 2019 and remained open for two weeks. Respondents were
eligible for 2 Continuing Education (CE) credits for survey completion.
Measures
The following section describes how key study variables were collected and
measured (see Table 1.1 for more information).
Gender
For the independent variable gender, participants were asked to answer one of the
following three options: “Female,” “Male,” or “Other (please specify).” To maintain a
straightforward interpretation of the regression coefficient, the latter was removed from
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analysis, with the remaining variables coded using a 0/1 binary scheme and calculated as
a categorical variable.
Experience
For the independent variable years of experience, participants were asked to select
one of five options: “Less than 5 years,” “6-10 years,” “11-20 years,” “21-30 years,” or
“More than 30 years.” Responses were scored quantitatively as continuous ratio data.
Age
Participant age was calculated as a continuous variable after removing all
incomplete and non-integer responses. Respondents were provided with a free-form text
entry for the independent variable age.
Opioid-related Education
For the independent variable veterinary opioid education, participants were asked
to respond to the following two questions: “In veterinary school, I was instructed on best
practices for safe use, safe storage, and safe disposal of controlled substances (including
opioids),” and “In veterinary school, I received training on the potential for abuse/misuse
of controlled substances (including opioids).” Opioid education was calculated using a 5point Likert scale cumulative total of the following responses: “Strongly agree,”
“Somewhat agree,” “Neither agree nor disagree,” “Somewhat disagree,” and “Strongly
disagree.”
Opioid Sum Score
To calculate the sum score of opioids (i.e. opioid prescribing rate), representing
the dependent variable, quantitative ratio data was collected from responses to questions
12, 13, 14, 27, 28, and 29 (see Appendix A) asking participants to estimate the number of
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times per week they administer or prescribe certain controlled substances. For the
purpose of this study, only responses to the following opioid controlled substances were
included: hydromorphone, morphine, fentanyl, codeine, hydrocodone, buprenorphine,
and butorphanol. To create the sum score, all responses that selected "More than 20
times" were given 5 points, "11-19 times" were assigned 4 points, "6-10 times" was
assigned 3 points, "Fewer than 5 times" was given 2 points, and “Never” was assigned 1
point. All these responses were then summed across items to create one continuous
measure of opioid prescribing behavior.
Data Analysis
At the completion of the survey window, Qualtrics data were downloaded into a
Statistical Package for the Social Sciences (SPSS version 26.0) to perform statistical
analyses. Descriptive statistics were calculated for the data on demographics including
mean age, number of years in practice, and gender distribution (see Table 1.1). To
examine the research question, a hierarchical multiple regression model was conducted to
assess whether veterinarians’ characteristics, including gender, age, experience, and
opioid education, could predict opioid prescribing rates. Using hierarchical multiple
regression provided a variance model of analysis between these independent factors and
the sum score of opioids prescribed as the dependent variable. The regression model was
calculated using the standard multiple linear regression equation: y = b1*x1 + b2*x2 +
b3*x3…+ c, where y = opioid prescribing rate, b = the regression coefficients for linear
effect, c = the random error for y in observation, and x = each independent veterinary
provider characteristic. Independent variables were entered simultaneously into the
model; an F-test in one-way ANOVA was used to assess the overall significance of the
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regression model. The strength of the relationship between the multiple regression model
and the dependent variable was assessed with a goodness of fit measure indicated by R2
(the coefficient of multiple determination).
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CHAPTER IV: RESULTS
The purpose of this study was to assess whether variations in provider
characteristics influence veterinary opioid prescribing behaviors. To predict opioid
prescribing rate, a hierarchical multiple regression model was carried out. Gender, age,
years of experience, and opioid education were chosen as independent predictors in the
veterinary model. The multiple regression model representing age, gender, and
experience predicted R2 =.05, F(3, 356) = 6.76, p < 0.05. The variance model with all
four predictors including opioid education produced R2 =.09, F(4, 352) = 8.52, p < 0.05.
Table 1.1 summarizes the descriptive statistics and analysis results for provider
characteristics.
Table 1.1

Descriptive Statistics for Veterinary Provider Characteristics

Mean

Age
399
29
47.79

Experience
402
26
3.21

Opioid Education
363
65
13.3774

Median

47.00

3.00

13.0000

Std. Deviation

12.790

1.364

4.55515

Minimum

24

1

2.00

Maximum

79

5

30.00

N

Valid
Missing

Gender
403
25

The results of the regression indicated that 5.4% of the variance in opioid
prescribing rate can be explained by veterinary provider characteristics. When including
opioid education during veterinary school, the model improves slightly to predict 9% of

21
the variance. Both variance models met the F-test for overall significance. In the first
variance model, two of the four independent variables were statistically significant, with
younger age and male gender predicting higher opioid prescribing rates (see Table 1.2 for
results).
Table 1.2

Model
(Constant)

Multiple Regression Model for Gender, Age and Experience
Unstandardized
Coefficients
B
Std. Error
15.853
1.217

Standardized
Coefficients
Beta

t
13.025

Sig.
.000

Age

-.113

.049

-.314

-2.317

.021

Gender

1.393

.477

.153

2.918

.004

Experience

.647

.447

.196

1.448

.148

Dependent variable Opioid prescribing rate
R2= .054

In the second regression model, opioid education was included as an additional
independent predictor and found to be significant (p < 0.05). Gender remained
statistically significant in this analysis, with male gender predicting higher opioid
prescribing than female gender, though age was no longer associated with a higher opioid
prescribing rate. In both regression models, years of experience was not a significant
predictor of opioid prescribing behavior. See Table 1.3 for a summary of multiple
regression data including opioid education.
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Table 1.3

Multiple Regression Model for Gender, Age, Experience and Education

Model
(Constant)

Unstandardized
Coefficients
B
Std. Error
15.632
1.198

Standardized
Coefficients
Beta

t
13.045

Sig.
.000

Age

-.087

.048

-.241

-1.787

.075

Gender

1.230

.471

.135

2.608

.009

Experience

.395

.445

.120

.889

.375

Opioid education

.035

.010

.187

3.615

.000

Dependent variable Opioid prescribing rate
R2= .088

23

CHAPTER V: DISCUSSION
Researchers often select provider characteristics as a tool for outcome measures
because attributes such as age or gender can influence behaviors in measurable and
meaningful ways; exploring the degree of association between demographic variables and
outcomes has a long historical presence in research studies (Goldberg, Sweeney,
Merenda & Edward Hughes, Jr., 1998). Studying opioid prescribing behavior in
association with provider characteristics has allowed researchers to conclude that the
decision to prescribe an opioid may in some ways be influenced by age, gender, years of
experience, or other provider characteristics (Lebovits et al., 1997). This is important
considering that the decision to prescribe an opioid should follow evidence-based
guidelines and not be influenced by provider characteristics (Lazkani et al., 2015).
This research was undertaken to examine whether variations in veterinary
provider characteristics such as gender, age, experience and opioid education can predict
opioid prescribing behaviors. These same provider characteristics have been shown to
impact the opioid prescribing rate of human physicians, raising questions as to whether a
similar pattern exists in veterinary medicine.
One significant predictor in our model was gender. Females tended to have
slightly higher opioid prescribing rates as compared to male veterinarians. A possible
reason for this may be because in general, female veterinarians score higher on empathy
toward animals than their male colleagues, and female gender more positively correlates
with issues of animal welfare (Colombo, Crippa, Calderari & Prato-Previde, 2017;
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Apostol, Rebega & Miclea, 2013). Empathetic veterinarians have been shown to score
animals’ pain higher and have greater perception toward pain in animals (Colombo et al.,
2017). This may result in the higher opioid prescribing behavior seen by female
veterinarians in this study.
Another significant predictor in veterinarian prescribing behavior was age.
Younger participants were associated with slightly higher prescribing rates, while studies
of human physicians trended in the opposite direction, showing older physicians to be
associated with higher prescribing rates (Varney et al., 2016). Notably, when the
education variable was added into the model, age was no longer a significant predictor.
This could be promising as education could be an effective route to intervention. This
may also be why age was no longer significant when opioid education was introduced as
a variable: pain management is not new to the veterinary curriculum, so veterinarians,
regardless of age, would have experienced hours of training during medical school (Firth,
2016).
Finally, opioid education was significantly predictive of prescribing behavior in
veterinarians. Interestingly, receiving more opioid education during veterinary school
was associated with slightly increased opioid prescribing behavior. While this may seem
contradictory, increased confidence has been found to be an important outcome of
medical education regarding opioid prescribing practices (Pearson, Moman, Moeschler,
Eldrige & Hooten, 2017). Providers who reported confidence in pain management were
more likely to use a consistent approach when prescribing opioids and follow
recommended protocols (Pearson et al., 2017). Perhaps not unrelatedly, veterinarians
receive more education on pain management than other medical fields (Briggs, Carr, &
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Whittaker, 2011; Miró, Castarlenas, Solé, et al., 2019). On average, veterinary students
receive 87 hours of pain education (Foreman, 2014). In addition, the American
Veterinary Medical Association requires graduating students from accredited universities
to have fulfilled nine competency areas, one of which is pain management (American
Veterinary Medical Association, 2017). By contrast, medical students receive
substantially less pain education than their veterinary colleagues. In the U.S., the
American Association of Medical Colleges reported an average of only 8 to 16 hours of
pain education across a 4-year medical education, and of the eight core competency areas
laid out for graduating physicians by the AAMC-HHMI Scientific Foundations for Future
Physicians Committee, none mention pain (Foreman, 2014; Association of American
Medical Colleges, 2009). The relationship between veterinary education and opioid
prescribing seen in this study may help inform interventions targeting prescribing
behaviors, as findings from human medical literature consistently demonstrates a lack of
physician confidence in prescribing opioids (Pearson et al., 2017; Jamison, Scanlan,
Matthews, Jurcik & Ross, 2016).
Limitations
While there is value in the findings of the current study, this research has potential
limitations due to the challenges of the survey tool. Although the questions in this pilot
survey were guided by a review of comparable veterinary questionnaires and thoroughly
evaluated by content-experts from three different veterinary stakeholder groups, time and
scope allowed for only a preliminary validation of the survey tool. For example, the data
analysis phase revealed some unanticipated question interpretation discrepancies that
were not identified during the original content assessment. Additionally, survey questions
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were not always measured in meaningful ways that reflected real clinical practice
outcomes. For instance, years of experience was grouped into categories not necessarily
reflective of meaningful experience thresholds in practice. In future iterations of this
study, additional questions with refined measurement would allow for additional
predictors to be tested in the model; better developed questions would be able to capture
clinical use differences across specialty and how those variables reflect prescribing
behaviors. The current survey questions did not make such an investigation possible.
Second, this study utilized the sum score of opioids to calculate opioid prescribing
behavior. This grouped prescribing behavior into frequency categories which may not
have accurately reflected the full range and nuance of opioid prescribing behaviors.
Improving upon opioid surveillance measures would eliminate the limitations of creating
one continuous measure of opioid prescribing behavior as was calculated by the opioid
sum score in this study. For example, a more robust measurement of opioid prescribing
rate would be beneficial, such as the value of morphine milligram equivalents (MME)
commonly used to measure trends in opioid prescribing behavior. The questions used to
calculate the opioid sum score also required participants to estimate how many times a
week they used a particular drug, which could be challenging to remember and invites the
potential for recall bias.
Suggestions for Future Research
The results of this study indicate that provider characteristics do not account for a
large percentage of the variance in veterinary opioid prescribing behavior as predicted by
the opioid prescribing patterns of human physicians. This suggests that given the unique
complexities of the veterinary profession, additional population-specific research is
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needed to understand what factors do influence veterinary prescribing behavior.
Unfortunately, there is not a lot of information available about veterinary prescribing
behavior, and even fewer veterinary studies exploring opioid prescribing behavior. One
previous study conducted open interviews of veterinarians (n=5) to gain information on
veterinary prescribing and dispensing processes, but this kind of research is labor
intensive and not feasible for large-scale data collection (McDowell et al., 2011). Another
study by Clarke et al. (2019) obtained pharmacy records and conducted a retrospective
(11 year) cross-sectional review of all opioid prescriptions dispensed or prescribed within
the setting of a large, acute-care veterinary teaching hospital. While this kind of study
offers a more precise measurement of opioid prescribing behavior by removing the
limitations of self-reporting or potential recall bias, the results of this study were
restricted to one facility in one state, limiting generalizability for veterinarians in general
practices and hospitals in other states. Research would benefit from a measurement tool
with the ability to capture similar opioid prescribing data across different practice types
and locations.
Future veterinary studies exploring opioid prescribing behavior should also
consider a deeper investigation into what constitutes risky opioid prescribing behavior by
veterinarians. This study did not measure risky prescribing behaviors as data were
captured in a way that made it hard to identify risk thresholds. For example, while the
results of this study suggest provider confidence may potentially be the result of opioid
training received during medical school, it is unknown whether this is associated with
safe or risky opioid prescribing behavior. There are a number of assessment tools
designed to measure opioid prescribing risk available to providers. These instruments rely
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on stratification of the dangers associated with patient addiction and misuse potential,
however, many of these assessments are self-administered by patients or otherwise have
no application to animal patients in a veterinary setting. Future research would benefit
from a targeted measurement of risky opioid prescribing behavior developed from
clinical guidelines and opioid-prescribing protocols, applicable to veterinary providers.
Conclusions
The high overdose mortality of the opioid crisis has led public health agencies
such as the CDC, the DEA and the NIH to identify opioid over-prescribing behavior as a
primary driver in the opioid epidemic. Veterinarians are a subset of opioid prescribers, so
from a public health perspective, it is important to explore the potential connection
between veterinary medicine and the opioid epidemic. While veterinarians and physicians
share many common factors as medical providers, this study offers some evidence that
although provider attributes such as gender, age or experience can predict higher opioid
prescribing rates for human physicians, these characteristics are less likely to influence
opioid prescribing for veterinarians.
While the limits of this study cannot explain what factors cause variance in
veterinary opioid prescribing, these findings support the conclusion that they are different
from the factors influencing opioid prescribing behavior for human providers. Because
veterinary provider characteristics are not highly predictive of opioid prescribing
behavior, these findings could help inform and prioritize public health interventions,
time, and resources targeting veterinary opioid practices.
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